Abstract The 4-decade (1980–2017) trends in lymph node status of patients with vulvar
squamous cell carcinoma (VSCC) in a province of northern Italy were investigated …

OBJECTIVE: In 2009, FIGO modified staging of vulvar cancer—the performance of the new
classification relative to the prior system has not been assessed. We sought to investigate …

Purpose The objective was to identify trends in surgery and the outcomes of squamous cell
vulvar cancer in a population-based setting. Methods A total of 1113 patients with squamous …

Background. In patients with squamous cell carcinoma of the vulva, lymph nodal,
surgicopathologic variables have been studied rarely, although lymph node status is by far …

(1) Objective: In many Western countries, survival from vulvar squamous cell carcinoma
(VSCC) has been stagnating for decades or has increased insufficiently from a clinical …

Aim By means of comparing the 2009 staging with the 1994 staging for vulva carcinoma on
prognostic predicting, the essay aims to investigate the alterations of clinical decision due to …

OBJECTIVE: Inguinal lymph node (LN) metastasis is an important prognostic factor in vulvar
cancer. Our aims were to analyze the prognostic value of LN metastasis with regard to the …

Objective Lymph node ratio (LNR) can predict treatment outcome and prognosis in patients
with solid tumors. Aim of the present analysis was to confirm the concept of using LNR for …

Squamous cell carcinoma (SCC) of the vulva is the fourth most common gynecological
cancer, usually staged with the TNM or FIGO systems. Since 2009, FIGO staging has taken …

Background As the population at risk for pelvic nodal involvement remains poorly described,
the role of pelvic lymphadenectomy (LAE) in vulvar squamous cell cancer (VSCC) has been …